Conversations About Off Time In Patients With Parkinson Disease

EP: 1.Off Fluctuations in Parkinson Disease

EP: 2.Adjusting and Changing Treatment Regimens in Parkinson Disease

EP: 3.Recognition of Off Episodes in Parkinson Disease

Now Viewing

EP: 4.Conversations About Off Time In Patients With Parkinson Disease

EP: 5.Advanced Treatment Options in Parkinson Disease

EP: 6.Adjunctive Treatments and Apomorphine for Treatment of Parkinson Disease

EP: 7.Continuous Subcutaneous Apomorphine Infusion (CSAI) and TOLEDO Study in Parkinson Disease

EP: 8.CSAI and INFUS-ON Study for Treatment of Parkinson Disease

EP: 9.Continuous Subcutaneous Infusion Systems for Parkinson Disease and Patient Selection Criteria

EP: 10.Place of Continuous Subcutaneous Infusion Systems in Parkinson Disease Management

EP: 11.Clinical Experience With CSAI for Parkinson Disease

EP: 12.Place of Recent Approvals in Parkinson Disease Management

EP: 13.Patient Conversation and Adoption of CSAI in Clinical Practice

EP: 14.Clinical Nurse Educators, Dosing Titrations to Manage Parkinson Disease

Video content above is prompted by the following:

Physician-Patient Communication About Off Time

• Structured assessment using validated tools (Movement Disorder Society (MDS), Unified Parkinson's Disease Rating (UPDRS), Wearing Off Questionnaire-9 (WOQ-9), Hauser Diary)
• Dedicated time to discuss daily symptom patterns and medication response
• Use of accessible language and visual aids to explain pharmacokinetics
• Involvement of caregivers to provide collateral information
• Setting realistic expectations about treatment goals
• Shared decision-making approach to treatment selection
• Regular follow-up with focused reassessment of off time
• Discussion of impact on quality of life and function, not just motor symptoms
• Education about differentiating off symptoms from nonmotor manifestations